115 related articles for article (PubMed ID: 30337363)
1. Antitumor synergy with SY-1425, a selective RARα agonist, and hypomethylating agents in retinoic acid receptor pathway activated models of acute myeloid leukemia.
McKeown MR; Johannessen L; Lee E; Fiore C; di Tomaso E
Haematologica; 2019 Apr; 104(4):e138-e142. PubMed ID: 30337363
[No Abstract] [Full Text] [Related]
2. 2-Bromopalmitate targets retinoic acid receptor alpha and overcomes all-trans retinoic acid resistance of acute promyelocytic leukemia.
Lu Y; Yan JS; Xia L; Qin K; Yin QQ; Xu HT; Gao MQ; Qu XN; Sun YT; Chen GQ
Haematologica; 2019 Jan; 104(1):102-112. PubMed ID: 30076181
[TBL] [Abstract][Full Text] [Related]
3. Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist.
McKeown MR; Corces MR; Eaton ML; Fiore C; Lee E; Lopez JT; Chen MW; Smith D; Chan SM; Koenig JL; Austgen K; Guenther MG; Orlando DA; Lovén J; Fritz CC; Majeti R
Cancer Discov; 2017 Oct; 7(10):1136-1153. PubMed ID: 28729405
[TBL] [Abstract][Full Text] [Related]
4. A retinoic acid receptor-alpha (RAR alpha) selective agonist modulates procoagulant activity of acute promyelocytic cells and induces their differentiation into neutrophils.
Shibakura M; Koyama T; Ohsawa M; Kamiyama R; Hirosawa S
Blood; 1998 Jan; 91(2):724-5. PubMed ID: 9439352
[No Abstract] [Full Text] [Related]
5. NLS-RARα Inhibits the Effects of All-trans Retinoic Acid on NB4 Cells by Interacting with P38α MAPK.
Xiao C; Zhong L; Shan Z; Xu T; Gan L; Song H; Yang R; Li L; Liu B
Int J Med Sci; 2016; 13(8):611-9. PubMed ID: 27499693
[TBL] [Abstract][Full Text] [Related]
6. The selective retinoic acid receptor-α agonist AM580 fails to control autoimmune neuroinflammation.
Wang Q; Thome R; Rostami A; Ma CG; Zhang GX
Cell Mol Immunol; 2019 Aug; 16(8):727-729. PubMed ID: 31160758
[No Abstract] [Full Text] [Related]
7. Induction of microRNA-10a using retinoic acid receptor-α and retinoid x receptor-α agonists inhibits atherosclerotic lesion formation.
Lee DY; Yang TL; Huang YH; Lee CI; Chen LJ; Shih YT; Wei SY; Wang WL; Wu CC; Chiu JJ
Atherosclerosis; 2018 Apr; 271():36-44. PubMed ID: 29459264
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamics-Based Strategy of Using Retinoic Acid Receptor and Retinoid X Receptor Agonists to Induce MicroRNA-10a and Inhibit Atherosclerotic Lesion.
Lee DY; Chiu JJ
Methods Mol Biol; 2019; 2019():143-169. PubMed ID: 31359395
[TBL] [Abstract][Full Text] [Related]
9. The activation of RARα prevents surgery-induced cognitive impairments via the inhibition of neuroinflammation and the restoration of synaptic proteins in elderly mice.
Chen Y; Zhou Y; Cai J; Xu J; Hu C; Chen H; Hong Y; Pan N; Jiang Y; Zhou C; Wei H; Xu Z; Liu L; Wu X; Cui W
Int Immunopharmacol; 2024 Mar; 130():111772. PubMed ID: 38432148
[TBL] [Abstract][Full Text] [Related]
10. Forced retinoic acid receptor alpha homodimers prime mice for APL-like leukemia.
Sternsdorf T; Phan VT; Maunakea ML; Ocampo CB; Sohal J; Silletto A; Galimi F; Le Beau MM; Evans RM; Kogan SC
Cancer Cell; 2006 Feb; 9(2):81-94. PubMed ID: 16473276
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis and Evaluation of Indene Derivatives as Retinoic Acid Receptor α Agonists.
Guan X; Luo P; He Q; Hu Y; Ying H
Molecules; 2016 Dec; 22(1):. PubMed ID: 28035983
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil elastase is important for PML-retinoic acid receptor alpha activities in early myeloid cells.
Lane AA; Ley TJ
Mol Cell Biol; 2005 Jan; 25(1):23-33. PubMed ID: 15601827
[TBL] [Abstract][Full Text] [Related]
13. Promyelocytic leukemia retinoid signaling targets regulate apoptosis,tissue factor and thrombomodulin expression.
López-Pedrera C; Barbarroja N; Buendía P; Torres A; Dorado G; Velasco F
Haematologica; 2004 Mar; 89(3):286-95. PubMed ID: 15020266
[TBL] [Abstract][Full Text] [Related]
14. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.
He LZ; Tribioli C; Rivi R; Peruzzi D; Pelicci PG; Soares V; Cattoretti G; Pandolfi PP
Proc Natl Acad Sci U S A; 1997 May; 94(10):5302-7. PubMed ID: 9144232
[TBL] [Abstract][Full Text] [Related]
15. Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells.
Duprez E; Lillehaug JR; Gaub MP; Lanotte M
Oncogene; 1996 Jun; 12(11):2443-50. PubMed ID: 8649786
[TBL] [Abstract][Full Text] [Related]
16. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation.
Benoit G; Altucci L; Flexor M; Ruchaud S; Lillehaug J; Raffelsberger W; Gronemeyer H; Lanotte M
EMBO J; 1999 Dec; 18(24):7011-8. PubMed ID: 10601023
[TBL] [Abstract][Full Text] [Related]
17. A widely used retinoic acid receptor antagonist induces peroxisome proliferator-activated receptor-gamma activity.
Schupp M; Curtin JC; Kim RJ; Billin AN; Lazar MA
Mol Pharmacol; 2007 May; 71(5):1251-7. PubMed ID: 17290005
[TBL] [Abstract][Full Text] [Related]
18. TFG-RARA: A novel fusion gene in acute promyelocytic leukemia that is responsive to all-trans retinoic acid.
Chong ML; Cheng H; Xu P; You H; Wang M; Wang L; Ho HH
Leuk Res; 2018 Nov; 74():51-54. PubMed ID: 30292835
[No Abstract] [Full Text] [Related]
19. Epigallocatechin-3-gallate promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells via PTEN.
Yao S; Zhong L; Chen M; Zhao Y; Li L; Liu L; Xu T; Xiao C; Gan L; Shan Z; Liu B
Int J Oncol; 2017 Sep; 51(3):899-906. PubMed ID: 28766684
[TBL] [Abstract][Full Text] [Related]
20. Relapsed acute promyelocytic leukemia previously treated with all-trans retinoic acid: clinical experience with a new synthetic retinoid, Am-80.
Takeuchi M; Yano T; Omoto E; Takahashi K; Kibata M; Shudo K; Harada M; Ueda R; Ohno R
Leuk Lymphoma; 1998 Nov; 31(5-6):441-51. PubMed ID: 9922035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
